News 11 Sep 2023 Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients admin
News 07 Sep 2023 Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference admin
News 28 Aug 2023 Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders admin
News 28 Aug 2023 Daxor Corporation Reports a 20.64 Percent Increase in Diagnostic Test Kits Revenue From Prior Year Period in Form N-CSR Filing for the Six Months Ended June 30, 2023 admin
News 12 Jul 2023 JACC-HF Study Compares Daxor’s BVA-100® Volume Metric to CardioMEMS® Pressure Metric in Heart Failure Patients admin
News 11 Jul 2023 Daxor Corporation Announces Further Acquisitions and Increased Utilization of its BVA-100® Blood Volume Diagnostic Throughout the U.S. admin
News 05 Jul 2023 Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer admin
News 22 Jun 2023 Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering admin
News 20 Jun 2023 Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting admin
